BI Asset Management Fondsmaeglerselskab’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69K Buy
+5,086
New +$60.8K ﹤0.01% 621
2025
Q2
Sell
-3,405
Closed -$51K 865
2025
Q1
$51K Buy
+3,405
New +$52.4K ﹤0.01% 789
2021
Q4
Sell
-4,755
Closed -$156K 375
2021
Q3
$156K Hold
4,755
0.01% 360
2021
Q2
$144K Buy
+4,755
New +$157K 0.01% 376

Other funds holding OGN

BI Asset Management Fondsmaeglerselskab's OGN Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab opened a new position in Organon & Co (OGN) in Q2 2026: 5,086 shares worth $69K. The stake represents ﹤0.01% of the portfolio and ranks #621 among its holdings. This is a return to the name: BI Asset Management Fondsmaeglerselskab previously reported a position in OGN as recently as Q1 2025.

BI Asset Management Fondsmaeglerselskab first reported a position in OGN in Q2 2021 and has held it in 4 quarters since. The position peaked at $156K in Q3 2021. 368 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 5,086 shares of Organon & Co worth $69K as of Q2 2026.
  • Organon & Co was a new BI Asset Management Fondsmaeglerselskab position in Q2 2026.
  • Organon & Co made up ﹤0.01% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #621 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Organon & Co in Q2 2021 and has held it in 4 quarters since.
  • BI Asset Management Fondsmaeglerselskab's Organon & Co position peaked at $156K in Q3 2021.
  • 368 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.